Piccinno A | OMICS International
ISSN: 2167-065X

Clinical Pharmacology & Biopharmaceutics
Open Access

Our Group organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)

Piccinno A

Clinical Pharmacology Unit, Corporate Clinical Development Chiesi Farmaceutici S.p.A., Parma, Italy


Dr. Piccinno is affiliated to Clinical Pharmacology Unit, Corporate Clinical Development Chiesi Farmaceutici S.p.A., Parma, Italy. Her research interests reflect in his wide range of publications in various national and international journals. He published more than 15 scientific papers. He received more than 25 acknowledgments and outstanding awards.

Extrafine Beclometasone Dipropionate and Formoterol in Single and Separate Inhalers

The aim of this study was to evaluate the pharmacokinetics and pharmacodynamics of single administration of extrafine beclometasone (BDP)/formoterol hydrofluoroalkane (HFA) (Foster®, Chiesi Farmaceutici S.p.A., Italy) by pressurized metered dose inhaler (pMDI) in healthy volunteers, compared to the free combination of extrafine BDP pMDI (Q... Read More»

Piccinno A, Poli G, Monno R, Goethals F, Nollevaux F and Acerbi D

Research Article: Clin Pharmacol Biopharm 2012, 1:102

DOI: 10.4172/2167-065X.1000102

Abstract Peer-reviewed Full Article Peer-reviewed Article PDF